Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
10 hedge funds and large institutions have $6.28K invested in Coeptis Therapeutics Warrants in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
35% more capital invested
Capital invested by funds: $4.63K → $6.28K (+$1.64K)
3.91% more ownership
Funds ownership: 0% → 3.91% (+3.9%)
9% less funds holding
Funds holding: 11 → 10 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$1.38K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$245 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$235 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$346 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$107 |
| 3 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
-$60 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1 |
COEPW Hedge Fund Activity: Q1 2026 in Review
10 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2026, worth a combined $6.28K — up 35% from $4.63K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of COEPW and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Meteora Capital, opening a new position worth an estimated $1.38K. The largest seller was Landscape Capital Management, exiting entirely with an estimated $346 sold.
- 10 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2026, down from 11 in Q4 2025.
- Funds reported $6.28K of Coeptis Therapeutics Warrants stock for Q1 2026, up 35% quarter-over-quarter.
- 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2026 and 3 closed out, a net change of -1 holder.
- The largest Coeptis Therapeutics Warrants buyer in Q1 2026 was Meteora Capital, an estimated $1.38K added.
- The largest Coeptis Therapeutics Warrants seller in Q1 2026 was Landscape Capital Management, an estimated $346 sold.
Based on aggregated 13F filings for Q1 2026.